Comment on Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment

dc.contributor.authorYucel, Gul
dc.date.accessioned2026-04-04T13:35:12Z
dc.date.available2026-04-04T13:35:12Z
dc.date.issued2025
dc.departmentİnönü Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.doi10.1016/j.braindev.2025.104486
dc.identifier.issn0387-7604
dc.identifier.issn1872-7131
dc.identifier.issue6
dc.identifier.pmid41240611
dc.identifier.scopus2-s2.0-105021549639
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1016/j.braindev.2025.104486
dc.identifier.urihttps://hdl.handle.net/11616/109690
dc.identifier.volume47
dc.identifier.wosWOS:001620652400001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorYucel, Gul
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofBrain & Development
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.titleComment on Survival motor neuron protein is the optimal biomarker for evaluating the risdiplam treatment
dc.typeLetter

Dosyalar